Our lab focuses on mirror-image peptides and proteins, which have great therapeutic potential because of their resistance to proteolysis. Our primary biological interest is developing D-peptide inhibitors against infectious diseases, particularly for the prevention and treatment of HIV and antibiotic-resistant bacterial infections, though we are now expanding into diverse therapeutic areas including cancer.